# Ruxolitinib in Myelofibrosis Patients in Lombardy, Italy

> **NCT03959371** · — · UNKNOWN · sponsor: **Margherita Maffioli** · enrollment: 620 (estimated)

## Conditions studied

- Myelofibrosis

## Interventions

- **DRUG:** Ruxolitinib

## Key facts

- **NCT ID:** NCT03959371
- **Lead sponsor:** Margherita Maffioli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-04-11
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 620 (ESTIMATED)
- **Last updated:** 2019-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03959371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03959371, "Ruxolitinib in Myelofibrosis Patients in Lombardy, Italy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03959371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*